The Expression of BTLA Was Increased and the Expression of HVEM and LIGHT Were Decreased in the T Cells of Patients with Rheumatoid Arthritis [corrected].
Currently, the pathogenesis of rheumatoid arthritis (RA) is not clearly understood. The LIGHT/HVEM/BTLA co-signaling pathway may be involved in the pathogenesis of RA, although reports on the expression levels of LIGHT, HVEM and BTLA in T lymphocytes from RA patients are limited.In this study, we re...
Main Authors: | Bin Yang, Zhuochun Huang, Weihua Feng, Wei Wei, Junlong Zhang, Yun Liao, Linhui Li, Xinle Liu, Zhiqiang Wu, Bei Cai, Yangjuan Bai, Lanlan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4868345?pdf=render |
Similar Items
-
Correction: The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis.
by: Bin Yang, et al.
Published: (2017-01-01) -
BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
by: Claire Battin, et al.
Published: (2022-08-01) -
BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation – design, synthesis and biological evaluation
by: Katarzyna Kuncewicz, et al.
Published: (2023-09-01) -
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
by: Fabrice Barlesi, et al.
Published: (2023-05-01) -
Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Published: (2023-07-01)